This content is machine translated Non-Hodgkin's Lymphoma Pomalidomide in high-risk patients. Because data on the efficacy of pomalidomide in high-risk relapsed/refractory multiple myeloma populations are sparse, a phase II study set out to evaluate the agent in patients with GEP70 or…
View Post 6 min This content is machine translated Interview at ASCO GI on new data from the OPUS study. “We are a good step closer to personalized therapy in mCRC” In the treatment of metastatic colorectal cancer, there were new results on subgroup analyses of the OPUS trial at this year’s ASCO GI in San Francisco. As previously shown in…
View Post 3 min This content is machine translated Follicular lymphoma Rituximab in maintenance monotherapy. A study presented at ASH 2013 in New Orleans examined the role of rituximab in maintenance therapy in patients with follicular lymphoma. The study showed that the drug, when applied…
View Post 3 min This content is machine translated Newly diagnosed multiple myeloma Does a proteasome inhibitor offer new therapeutic options? One study discussed at the ASH meeting involved a regimen consisting of oral MLN9708 administered twice weekly plus lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma. It concludes…
View Post 4 min This content is machine translated Metastatic colorectal carcinoma To what extent does aspirin affect survival? More recently, studies have shown that aspirin improves overall survival in subgroups with colorectal cancer, specifically those with PIK3CA mutations. To test whether regular aspirin use is associated with survival…
View Post 4 min This content is machine translated 1st Swiss Symposium Peritoneal Malignancies and HIPEC Enabling individualized treatment At the first Swiss symposium on peritoneal malignancies and HIPEC in St. Gallen, experts spoke on the topics of ovarian cancer and metastatic colorectal cancer. It was about current and…
View Post 2 min This content is machine translated Lymphomas Integrative lymphoma diagnostics plays a central role For lymphoma diagnosis, a multimodality additive approach, which consists of history taking, clinical examination, laboratory parameters, histopathological findings, genetic findings, and static or functional (e.g., PET-CT, spectroscopy) imaging, is essential.
View Post 5 min This content is machine translated Early detection begins in the family doctor's office Melanocytic nevi and malignant melanoma Melanocytic nevi are the most common benign neoplasms in fair skin types. Their number is a risk indicator for the development of malignant melanoma, of which they may be precursors.…
View Post 6 min This content is machine translated Nodal lymphoma from the pathology point of view Update for daily practice A persistent lymphadenopathy is a clear indication for further histopathological diagnosis. A detailed medical history as well as knowledge of previous diseases, manipulations and drug therapies are essential for a…
View Post 2 min This content is machine translated Multiple Myeloma Media Workshop Which form of therapy is suitable for whom? At a media workshop during the ASH Congress in New Orleans, some key points of myeloma research were presented. They also discussed what these innovations mean for patients and used…
View Post 6 min This content is machine translated Highlights from the 100th anniversary of the Dermatological Outpatient Clinic The sexually transmitted diseases in focus As part of the centenary of the Dermatological Outpatient Clinic, an STI Continuing Education Day of the Swiss Society of Dermatology and Venereology was held at the Triemli in November…
